Curated News
By: NewsRamp Editorial Staff
February 25, 2026
SBC Medical Invests in OrangeTwist to Drive U.S. Aesthetics Market Expansion
TLDR
- SBC Medical's investment in OrangeTwist provides first-mover advantage in underserved U.S. markets, leveraging synergies to capture growth in the $48 billion medical aesthetics industry.
- SBC Medical partners with OrangeTwist to combine operational expertise with advanced management systems, pursuing joint operations and product development across U.S. and Asian markets.
- This partnership expands access to non-invasive aesthetic treatments that enhance wellness and healthspan, supporting longer, healthier lives for aging populations worldwide.
- SBC Medical's global expansion strategy transforms local aesthetic clinics into a trusted international brand through replicable partnership models and standardized high-quality services.
Impact - Why it Matters
This partnership represents a significant shift in the global medical aesthetics landscape, bringing together Japanese operational expertise with American market presence to address growing consumer demand for non-invasive treatments. For consumers, this means increased access to standardized, high-quality aesthetic services at competitive prices, particularly in underserved "white space" markets. The collaboration also signals broader industry trends toward personalized longevity solutions and preventative healthcare, potentially accelerating innovation in anti-aging treatments and making advanced aesthetic services more accessible worldwide. As populations age globally and demand for non-surgical cosmetic procedures continues to rise, this type of cross-border partnership could set new standards for quality, affordability, and service consistency in the rapidly expanding beauty and wellness sector.
Summary
SBC Medical Group Holdings Inc., a Japanese aesthetic medical clinic operator with 258 affiliated clinics worldwide and over six million annual patient visits, has made a strategic investment in OrangeTwist, a U.S.-based medspa chain with 24 locations across six states. This partnership marks SBC's official entry into the lucrative U.S. medical aesthetics market, which is projected to grow from $34 billion to $48 billion by 2030, driven by demand for non-invasive treatments like injectables, fillers, and laser therapies. The collaboration will leverage OrangeTwist's advanced management system and SBC's operational expertise to pursue joint operations, develop branded products, and address "white space" markets where high demand exists but few competitors operate.
Key players in this expansion include healthcare-focused private equity firm Hildred Capital and specialized asset management company Athyrium Capital, both longstanding institutional shareholders in OrangeTwist. Stephen Rodgers, global head of planning and strategy at SBC Medical, emphasized in an interview with Benzinga that the company seeks local partnerships that align with its mission and can scale effectively, rather than simply replicating its Japanese model. This approach is part of SBC's broader global expansion strategy, which also includes growth in Japan and Southeast Asia through partnerships with high-performing regional operators.
The partnership positions both companies to capitalize on the rapidly growing longevity industry, which is shifting from merely extending lifespan to boosting "healthspan" through personalized, preventative solutions. According to Gabelli Research, the global anti-aging market is expected to surpass $120 billion by 2030, with North America accounting for approximately 30% of this market. SBC believes its existing infrastructure and track record in providing high-quality, cost-efficient aesthetics services make it well-positioned to offer longevity-related products and services, including AI-powered diagnostics and regenerative therapies. This strategic move represents more than just market expansion—it's about creating a globally trusted brand for aesthetic beauty services through replicable partnership models that ensure consistent quality and pricing across different regions.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, SBC Medical Invests in OrangeTwist to Drive U.S. Aesthetics Market Expansion
